Evidence map›Paper›PMID 37932452›Full record

ArticleNature cell biology2023

GATA transcription factors drive initial Xist upregulation after fertilization through direct activation of long-range enhancers.

Liat Ravid Lustig, Abhishek Sampath Kumar, Till Schwämmle, Ilona Dunkel, Gemma Noviello, Elodie Limberg, Raha Weigert, Guido Pacini, René Buschow, Afrah Ghauri and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Xist in X chromosome inactivation: mechanisms and disease relevance.Cell communication and signaling : CCS · 2025
    Review
  6. Article
  7. Genome research · 2025
    Article
  8. The in vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Liat Ravid LustigSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Abhishek Sampath KumarDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0001-7918-6706
Till SchwämmleSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Ilona DunkelSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Gemma NovielloSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0001-5212-0803
Elodie LimbergSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Raha WeigertDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Guido PaciniSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
René BuschowMicroscopy and Cryo-Electron Microscopy, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-9800-2578
Afrah GhauriSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Maximilian StötzelDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Lars WittlerTransgenic Unit, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Alexander MeissnerDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0001-8646-7469
Edda G SchulzSystems Epigenetics, Otto Warburg Laboratories, Max Planck Institute for Molecular Genetics, Berlin, Germany. edda.schulz@molgen.mpg.de.ORCID 0000-0003-1253-6868
Max Planck Institute for Molecular Genetics · DE

Funding

BIOBEHAVIORAL STUDIES OF NARCOTICS ABUSE IN HUMANSK05DA000064 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI MENDELSON, JACK H · 1985 to 2007
$911k
NIDA NIH HHS K05 DA000064
6 · The paper itself

Abstract

X-chromosome inactivation (XCI) balances gene expression between the sexes in female mammals. Shortly after fertilization, upregulation of Xist RNA from one X chromosome initiates XCI, leading to chromosome-wide gene silencing. XCI is maintained in all cell types, except the germ line and the pluripotent state where XCI is reversed. The mechanisms triggering Xist upregulation have remained elusive. Here we identify GATA transcription factors as potent activators of Xist. Through a pooled CRISPR activation screen in murine embryonic stem cells, we demonstrate that GATA1, as well as other GATA transcription factors can drive ectopic Xist expression. Moreover, we describe GATA-responsive regulatory elements in the Xist locus bound by different GATA factors. Finally, we show that GATA factors are essential for XCI induction in mouse preimplantation embryos. Deletion of GATA1/4/6 or GATA-responsive Xist enhancers in mouse zygotes effectively prevents Xist upregulation. We propose that the activity or complete absence of various GATA family members controls initial Xist upregulation, XCI maintenance in extra-embryonic lineages and XCI reversal in the epiblast.

Indexed as

GATA Transcription FactorsRNA, Long NoncodingAnimalsFemaleFertilizationMammalsMiceUp-RegulationX ChromosomeX Chromosome InactivationGATA Transcription FactorsRNA, Long NoncodingXIST non-coding RNA

Identifiers

PMID37932452
PMCPMC10635832
OpenAlexW4388410062

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.